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Abstract
Objective: To identify and appraise published evidence of the measurement proper-
ties for epilepsy-specific patient-reported outcome measures (PROMs) of children's 
health-related quality of life (HRQoL).
Methods: We searched multiple databases for studies evaluating the measurement 
properties of English-language epilepsy-specific PROMs of children's HRQoL. We 
assessed the methodological quality using the COnsensus-based Standards for the se-
lection of health Measurement INstruments (COSMIN) guidance. We extracted data 
about the content validity, construct validity, internal consistency, test-retest reliabil-
ity, proxy reliability, responsiveness, and precision, and assessed the measurement 
properties with reference to standardized criteria.
Results: We identified 27 papers that evaluated 11 PROMs. Methodological quality 
was variable. Construct validity, test-retest reliability, and internal consistency were 
more commonly assessed. Quality of Life in Childhood Epilepsy (QoLCE) question-
naires are parent-reported and evaluated more than other PROMs; QoLCE-55 has 
good and replicated evidence for structural and construct validity and internal consist-
ency. Health-Related Quality of Life Measure for Children with Epilepsy (CHEQoL) 
has both child and parent-reported versions and good evidence of content, structural, 
and construct validity.
Significance: This review identified two leading candidate epilepsy-specific PROMs 
for measuring health-related quality of life in children. Establishing evidence of 
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1 |  INTRODUCTION
Epilepsy is a common, chronic neurological condition that 
is characterized by a tendency to have recurring seizures.1 
Epilepsy occurs in people of all ages and affects around 
3.2 in 1000 children in Europe.2 There are a number of 
different pediatric epilepsy syndromes of which childhood 
epilepsy with centrotemporal spikes (CECTS) is the most 
common.3 Epilepsy is associated with a range of cogni-
tive, psychiatric, social, and language issues that can lead 
to considerable challenges for the child and their family.4 
Typically, seizures are treated with antiepileptic medica-
tions, although the child can often incur unwanted side 
effects.4,5
Health-related quality of life (HRQoL) is an increasingly 
important focus for research in childhood epilepsy due to 
the medical, social, and psychological complications of 
seizures and antiepileptic medications. A patient-reported 
outcome measure (PROM) is a standardized questionnaire 
that is completed by a patient to measure their perception 
of their own health, well-being, and/or HRQoL; there may 
be proxy versions for carers to complete. Some PROMs are 
generic and designed for use across all health conditions 
and others are condition-specific. PROMs may focus on a 
singular aspect of health or have several domains that mea-
sure the multifaceted dimensions of HRQoL. PROMs are 
used widely to inform clinical practice such as monitoring 
a patient's health in national audits of health services and 
for collecting information on treatment outcomes for clin-
ical trials.6,7
A number of reviews have highlighted the condition-spe-
cific and generic PROMs that are available for use in pedi-
atric epilepsy.8‒14 For a PROM to be considered robust it 
needs to meet the standard criteria for measurement prop-
erties such as does the PROM measure what it purports to 
measure and is it understandable by the target population 
(validity), does the PROM measure this in the popula-
tion in the same way each time (reliability), does it detect 
changes accurately without measurement error (precision), 
and how much change is meaningful to patients and consid-
ered clinically important (responsiveness). Initiatives such 
as COnsensus-based Standards for the selection of health 
Measurement INstruments (COSMIN) have been established 
and recently updated to provide researchers with standard-
ized, evidence-based resources to appraise the measurement 
properties of PROMs and a framework for conducting sys-
tematic reviews.15,16
In this review, our aim was to examine which epilep-
sy-specific PROMs of children's HRQoL can be considered 
robust by finding, appraising, and summarizing evidence 
from published studies evaluating their measurement 
properties.
2 |  METHODS
2.1 | Search strategy
We identified PROMs using structured, systematic re-
view methods described in our protocol.17 Our electronic 
search strategy used the names of known childhood epi-
lepsy questionnaires, identified by an existing systematic 
review.9 In addition, we combined terms for epilepsy with 
generic terms for PROMs such as questionnaire, meas-
ure, tool, and scale. The databases CENTRAL (via the 
Cochrane Library), MEDLINE (via OvidSp), EMBASE 
(ViaOvidSp), PsycINFO (via OvidSp), and CINAHL (via 
EBSCOhost) were searched in May 2018 by MR (Appendix 
S1). We searched for additional relevant papers in the ref-
erence lists of included papers and we undertook forward 
reference searching via Google Scholar by checking arti-
cles that cited the original questionnaire validation articles. 
(DKP); Waterloo Foundation Project Grant 
164-3020 (DKP); Charles Sykes Epilepsy 
Research Trust (DKP); NIHR Specialist 
Biomedical Research Centre for Mental 
Health of South London; and Maudsley 
NHS Foundation Trust (DKP).
the responsiveness of PROMs is a priority to help the interpretation of meaningful 
change scores.
K E Y W O R D S
children, epilepsy, paediatric, patient-reported outcome measures, young people
Key points
• We identified 27 papers that evaluated the meas-
urement properties of 11 epilepsy-specific PROMs 
of children's HRQoL.
• PROMs with more evidence of robust measure-
ment properties included the QoLCE-55, QoLCE-
76 (parent-only report), and CHEQoL (parent and 
child reported).
• Evidence of responsiveness is lacking for epi-
lepsy-specific PROMs of HRQoL in children, 
which limits understanding of how much change 
in scores is perceived important and exceeds 
measurement error.
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We contacted the corresponding author of each included 
article to confirm that we had not missed any other relevant 
articles. The search strategy was recorded in a PRISMA 
flowchart (Figure 1).
2.2 | Inclusion and exclusion criteria
Articles were selected if they evaluated the measurement 
properties of epilepsy-specific PROMs for children (or by 
parent/caregiver proxy report). We only considered articles 
published in peer-reviewed journals. Articles were excluded 
if (a) the article was not an English-language paper, or not 
an evaluation of an English-language version of the ques-
tionnaire, (b) not a full report (eg, conference abstracts were 
excluded if a paper was not subsequently published), (c) not 
focusing on children aged 5-16, unless data on children could 
be extracted separately, (d) not an evaluation of measurement 
properties, (e) not a patient-reported, or parent-reported, out-
come measure assessing epilepsy-specific Health-Related 
Quality of Life (HRQoL).
2.3 | Study selection
Two reviewers (MR and HM) independently reviewed all ti-
tles and abstracts obtained from the literature searches. Any 
disagreements were arbitrated by a third reviewer (CM).
The full texts of all potentially eligible studies were re-
trieved. Two reviewers (HC and HM) independently assessed 
each full text against the exclusion criteria. Disagreements 
were resolved by discussion between the two reviewers or ar-
bitrated by a third reviewer (CM).
2.4 | Data extraction
First, descriptive data were extracted from included papers. 
Second, data were extracted on the measurement properties 
of the PROMs, which included content validity from qualita-
tive research and/or any theoretical framework, structural va-
lidity determined using factor analysis, internal consistency 
of scales, construct validity evaluated by correlation with 
other scales, and hypothesis testing to verify scales measure 
F I G U R E  1  Flowchart illustrating 
identification and selection of eligible 
studies
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the intended construct, test-retest reliability, proxy reliabil-
ity between child and parent, precision, and responsiveness 
(whether change in scores are considered robust).
2.5 | Risk of bias analysis
We assessed each included paper for its methodological qual-
ity using the COSMIN risk of bias (RoB) checklist for use in 
the systematic reviews of PROMs.15,16 Using the checklist, we 
assessed the bias of each paper for how the following seven 
properties had been tested: content validity, structural valid-
ity, construct validity, internal consistency, test-retest reliabil-
ity, precision, and responsiveness. We rated any measurement 
property evaluated in each paper using the COSMIN four-point 
scale: “very good,” “adequate,” “doubtful,” “inadequate.”
2.6 | Synthesis of results
We synthesised all evidence of methodological quality of 
studies and measurement properties of PROMs using stand-
ard reference criteria as we have done in other similar re-
views.18 We interpreted the evidence for each questionnaire 
into an overall rating of evidence and collated this into a sum-
mary appraisal table (Table 4). Two reviewers (HC and CM) 
appraised the information and agreed a summary rating. We 
provide a brief succinct narrative synthesis of the findings in 
the results; fuller details of data extracted with longer narra-
tive are available in the supplementary files (Appendix S2).
3 |  RESULTS
We found 27 studies that evaluated the measurement prop-
erties of 11 epilepsy-specific PROMs of children's HRQoL 
(Figure 1). Authors of the articles that we contacted did not 
suggest any further papers that we had not already included. 
Of the 11 PROMs, QoLCE-76 has three shortened versions, 
and the Impact of Childhood Illness (ICI) scale PROM has 
two prior versions. Collectively, the PROMs are for children 
aged 3  months to 18  years of age with epilepsy and were 
developed in the UK, Europe, USA, Canada, and Australia 
(Tables 1 and 2). The methodological quality of the included 
studies was variable across a range of measurement proper-
ties (Table 3). Construct validity, test-retest reliability, and in-
ternal consistency were more commonly assessed properties 
across studies; evaluations of responsiveness and precision 
were lacking (Table 4, Appendix S2).
Impact of Childhood Illness scale is a parent-rated 
30 item PROM.19,20 The ICI evolved from the Adult's 
Attitudes to Children with Epilepsy Visual Analogue Scale 
and the Modified Impact of Epilepsy Schedule (Tables 1 
and 2).21,22 The evaluation of content validity of the ICI 
was rated as doubtful/inadequate due to poor description 
of development.20 However, ICI has evidence of good 
structural validity and the two domains (Frequency and 
Importance) have excellent internal consistency (α = 0.92-
0.94).19,23 In addition, ICI has some evidence of construct 
validity, as demonstrated by a moderate correlation with 
the Hague Restrictions in Childhood Epilepsy (HARCES) 
PROM (r = .60).19,23
HARCES is a parent-rated 10-item PROM (Tables 1 and 
2).23 HARCES was developed by asking parents of children 
with epilepsy to list daily life activities limited by epilepsy, 
but the study rated as doubtful due to limited details about 
the development. HARCES demonstrates good internal 
consistency (α = 0.89) and test-re-test reliability (r2 = .93). 
Construct validity was assessed by correlating HARCES 
scores and clinical variables but with few substantive 
findings.23,24
Quality of life in Epilepsy Inventory for Adolescents 
(QoLIE-AD-48) is a 48-item PROM (Tables 1 and 2).25 
QoLIE-AD-48 items were devised based on a literature re-
view, existing measures, and focus groups, but was rated as 
doubtful for its risk of bias because of limited description of 
the methods of development. Structural validity was assessed 
using factor analysis on 191 participants, but the method 
was rated inadequate due to an inadequate sample size. 
Supporting evidence was found for the internal consistency 
of the overall scale, and subscales met the standard criteria 
except the three-item health perception scale (α = 0.52). Test-
retest reliability and construct validity were good (Table 4).
Quality of Life in Paediatric Epilepsy Scale (QoLPES) is a 
20-item PROM (Table 1 and 2). There are parallel child- and 
parent-report versions. Scale items were devised following con-
sultation with children and parents who were asked to list in 
order of importance their concerns, which were then aggregated 
by the study researchers; the study was rated methodologically 
adequate, providing evidence of content validity (Table 4).26
Quality of Life in Childhood Epilepsy (QoLCE) is a par-
ent-reported PROM. It has four questionnaire versions with 
different numbers of items: QoLCE-76, QoLCE-55, QoLCE-
16, and a single item G-QoLCE (Table 1 and 2).27‒34 The orig-
inal QoLCE-76 was developed by a literature review and by 
adapting items from established instruments. A focus group 
of epilepsy patients and professionals reviewed the question-
naire for its content and clarity, but this was not described 
thoroughly, so was rated doubtful for its risk of bias (Table 4, 
Appendix S2). QoLCE-76 has excellent internal consistency 
for the overall summary score and the subscales have good 
internal consistency.28 There is extensive evidence of con-
struct validity from two studies, with one study demonstrat-
ing that the QoLCE-76 correlated moderately to highly with 
similar scales on the established Child Health Questionnaire 
Parent Form (CHQ-P50) (Table 4).27,28
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T A B L E  1  Epilepsy-specific patient reported outcome measures (PROMs)
No.
Instrument 
version Author Purpose No. of items and domains
Age 
range
Country/
origin Respondent
1a Adult's Attitudes 
to Children 
with Epilepsy: 
Visual 
Analogue Scale
Hoare 
(1986)22
Assess adult's 
attitudes to 
children with 
epilepsy
47 items, 7 domains: 
Physical consequences 
of a single fit; Aetiology 
of epilepsy; Problems for 
the child at present and 
in the future; Side effects 
of drugs; Problems for 
the child's parents; Social 
restrictions or the child 
and his family; Adverse 
effects of family life
10 Edinburgh, UK Parent
1b Modified Impact 
of Epilepsy 
Schedule
Hoare 
(1993)21
Assess adult's 
attitudes to 
children with 
epilepsy and the 
impact on adults
39 items, 3 domains: 
The medical care and 
treatment of epilepsy; 
The child's adjustment 
and development; Effects 
on family life
5-15 y Edinburgh, UK Parent
1c The Impact of 
Childhood 
Illness Scale 
(ICI)
Hoare et al 
(2000)19
Assess the 
impact of 
epilepsy/
long-standing 
childhood 
illness on QoL 
on the child and 
family
30 items, 4 domains: 
Impact on the child's 
development and 
adjustment; impact on 
the parents; and impact 
on the family and a 
combined total score. 
The instrument is scored 
on two dimensions: 
Frequency and 
Importance.
6-17 y Edinburgh, UK Parent
2 The Hague 
Restrictions 
in Childhood 
Epilepsy Scale 
(HARCES)
Carpay et al 
(1997)24
Quantify 
restrictions due 
to disability 
in childhood 
epilepsy
10 items, including 2 
global items
4-16 y Hague, 
Rotterdam
Parent
3 Quality of Life 
in Epilepsy 
Inventory for 
Adolescents 
(QoLIE-AD-48)
Cramer et al 
(1999)25
Assess HRQoL 
in adolescents 
with epilepsy
48 items, 8 domains: 
Epilepsy impact; 
Memory/concentration; 
Attitudes towards 
epilepsy; Physical 
functioning; Stigma; 
Social support; School 
behaviour; Health 
perceptions and a total 
summary score.
11-17 y USA & 
Canada
Child
4 Quality of Life 
in Pediatric 
Epilepsy 
(QoLPES)
Arunkumar 
et al 
(2000)26
To assess 
HRQoL in 
children with 
epilepsy
20 items 3 mo-18 y USA Parent & 
child
(Continues)
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No.
Instrument 
version Author Purpose No. of items and domains
Age 
range
Country/
origin Respondent
5a Quality of Life 
in Childhood 
Epilepsy 
(QoLCE)
Sabaz et al 
(2000) & 
Sabaz et al 
(2003)27,28
To assess 
HRQoL for 
children with 
epilepsy
Australian version: 73 
items, 16 subscales, 
covering 7 domains: 
Cognition, Physical 
activities, Social 
activities, Emotional 
wellbeing, Behavior, 
General health, General 
Quality of Life and a total 
score
USA version: 76 items, 
16 subscales, covering 
7 domains: Cognition, 
Physical activities, Social 
activities, Emotional 
well-being, Behavior, 
General health, General 
Quality of Life and a total 
score
4-18 y New South 
Wales, 
Australia & 
USA
Parent
5b QoLCE 55 Goodwin et 
al (2015)30
To assess 
HRQoL for 
children with 
epilepsy, in 
a shortened 
version
55 items, 4 domains: 
Cognitive; Emotional; 
Social and Physical
4-18 y Canada Parent
5c QoLCE 16 Goodwin et 
al (2018)33
To assess 
HRQoL for 
children with 
epilepsy, in 
a shortened 
version
16 items, 4 domains: 
Cognitive; Emotional; 
Social and Physical
4-18 y Canada Parent
5d G-QoLCE Conway et 
al (2018)34
To assess 
HRQoL for 
children with 
epilepsy with 
one item
1 item 4-18 y Canada Parent
6 Impact of 
Pediatric 
Epilepsy Scale 
(IPES)
Camfield et 
al (2001)35
To assess the 
influence of 
epilepsy on the 
major aspects of 
the family and 
child's life
11 items 2-16 y Canada Parent
7 Health-Related 
Quality of 
Life Measure 
for Children 
with Epilepsy 
(CHEQoL-25)
Ronen et al 
(2003)38
To measure the 
HRQoL of 
preadolescent 
children with 
epilepsy
25 items, 5 domains: 
Interpersonal/Social 
Consequences; 
Worries and Concerns; 
Intrapersonal/Emotional 
Issues; Epilepsy My 
Secret and Quest for 
Normality
6-15 y Canada Child and 
parent
T A B L E  1  (Continued)
(Continues)
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QoLCE-55 is a shortened version of the QoLCE-76 (Table 
2).30‒32 Structural validity was assessed in three studies using 
factor analysis. One study was rated as inadequate due to 
small sample size, but two other studies were rated as very 
good. QoLCE-55 total score and the individual subscales 
were shown to have excellent internal consistency. Two stud-
ies provide support for the construct validity of the QoLCE-
55; one study found a strong correlation between subscales of 
the CHQ-P50 with relevant subscales of the QoLCE-55 and 
weaker correlations with dissimilar constructs.30‒32 A further 
study indicated moderate to strong correlations with similar 
subscales of the KIDSCREEN-27 and weak to moderate cor-
relations with dissimilar subscales (Table 4, Appendix S2).30
QoLCE-16 has good structural validity and excellent in-
ternal consistency across all scales (a = 0.75-0.92) and for 
the overall scale (α = 0.90).33 Results that were reported pre-
viously using the QoLCE-55 and QoLCE-76 were compara-
ble to those generated using the QoLCE-16 model, providing 
evidence of construct validity (Table 4). The G-QoLCE is 
an overall QoL single-item question derived from QoLCE-76 
No.
Instrument 
version Author Purpose No. of items and domains
Age 
range
Country/
origin Respondent
8 DISABKIDS 
(Epilepsy 
Module)
Baars et al 
(2005)40
To assess the 
HRQoL of 
children and 
adolescents with 
epilepsy and 
their families
10 items, 2 domains: 
Impact and Social
4-16 y Collaboration 
of seven 
European 
countries 
(Austria, 
France, 
Germany, 
Greece, the 
Netherlands, 
Sweden and 
the United 
Kingdom)
Child and 
parent 
report 
(parent 
proxy for 
4-7-y olds)
9 Epilepsy and 
Learning 
Disability 
Quality of Life 
(ELDQoL)
Buck et al 
(2007)41
To assess 
HRQoL in 
children with 
both epilepsy 
and learning 
disabilities
70 items, 4 domains: 
Behaviour; Seizure 
severity; Mood and Side 
effects
2-18 y UK Parent
10 Glasgow 
Epilepsy 
Outcome Scale 
(GEOS-YP)
Townshend 
et al 
(2008)42
To assess the 
impact of 
epilepsy on an 
adolescent's 
QoL that 
is based on 
exploration of 
adolescent's 
views
50 items, 9 domains: Peer 
Acceptance; School/
work; Development 
of Autonomy; Future 
focus; Epilepsy as part of 
Me; Medication issues; 
Seizures, Knowledge 
about Epilepsy; Sense of 
Uncertainty
10-18 y Glasgow, 
UK Tertiary 
epilepsy 
centres
Child
11 PedsQL Epilepsy 
Module
Follansbee-
Junger et al 
(2016)44
To validate 
a brief and 
reliable 
epilepsy-
specific, health-
related quality 
of life (HRQoL) 
measure 
in children 
with various 
seizure types, 
treatments, and 
demographic
characteristics.
29 items, 5 domains: 
Impact; Cognitive; Sleep; 
Executive Function and 
Mood/behavior
2-18 y USA Parent only 
report (2-
4-y olds), 
and child 
and parent 
proxy 
report (aged 
5-18)
T A B L E  1  (Continued)
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with evidence of good construct validity and responsiveness 
(Table 4).34
The Impact of Paediatric Epilepsy Scale (IPES) is an 
11-item parent-report PROM (Table 1 and 2).35,36 Item de-
velopment has not been published. The PROM has good ev-
idence of structural validity and internal consistency. There 
was some evidence for construct validity. The responsiveness 
study over a 3-year time frame was rated methodologically 
doubtful due to risk of bias (Table 4).35
The Health-Related Quality of Life Measure for Children 
with Epilepsy (CHEQoL) is a 25-item PROM; the parent 
and child versions include some overlapping items but some 
differ.37‒39 CHEQoL items were devised through qualitative 
research with children with epilepsy. CHEQoL has good 
structural validity, assessed by factor analyses run separately 
on the child and the parent instruments.37 Internal consis-
tency was good for the four subscales in both the parent 
and child questionnaires. Test-retest reliability for the child 
questionnaire was acceptable (ICC = 0.59-0.69) in the 8- to 
15-year group but less so in the 6- to 7-year-olds, suggest-
ing the scale is robust for 8- to 15-year-olds. Test-retest re-
liability was adequate for the parent questionnaire; however, 
this study was rated doubtful due to a lack of detail about the 
stability of participants during the interim period. Construct 
validity of the CHEQoL was examined extensively.38 The 
different subscales demonstrated good to excellent discrim-
inative validity between children with fewer or more health 
problems related to their epilepsy, with one exception being 
the Secrecy subscale. Reliability between child and parent 
report was generally poor, indicating that these should be in-
terpreted separately.
DISABKIDS Epilepsy Module is a 10-item PROM de-
veloped to supplement the DISABKIDS chronic generic 
module (Table 1 and 2).40 The PROM has a child and parent 
version for 8- to 16-year-olds and a parent proxy version for 
4- to 7-year-olds. DISABKIDS Epilepsy Module was devel-
oped following extensive literature review, focus groups, and 
interviews carried out with patients with epilepsy and their 
parents. Structural validity was assessed by a factor analysis 
on 37 participants with epilepsy; the study was rated meth-
odologically inadequate for risk of bias due to sample size. 
DISABKIDS Epilepsy Module showed excellent internal 
consistency for the Impact domain (α = 0.89) and adequate 
for Social domain (α = 0.77).
The Epilepsy and Learning Disabilities Quality of Life 
(ELDQoL) is a 70-item, parent-reported PROM (Table 1 and 
2).41 ELDQoL was developed using interviews with parents 
and piloted, but this information was published only as a con-
ference abstract and excluded due to limited details available. 
The content of ELDQoL was assessed in interviews with 
parents and health professionals, and the study was rated 
methodologically doubtful due to lack of details. ELDQoL 
shows excellent internal consistency across the four scales; A
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test-retest reliability for each subscale was high. There is evi-
dence for construct validity.41
Glasgow Epilepsy Outcome Scale for Young People 
(GEOS-YP) is a 50-item, adolescent report PROM.42,43 Items 
were devised from focus groups.42 GEOS-YP was internally 
consistent for the total score and subscales. Test-retest reli-
ability was good, and the study was rated methodologically 
adequate. Construct validity was good and the GEOS-YP 
total correlated highly with the QoLIE-AD-48 total. There 
were moderate correlations between other scales that mea-
sured similar constructs.
Paediatric Quality of Life Inventory (PedsQL) Epilepsy 
Module is a 29-item PROM with parent and child versions 
and parent only for ages 2-4  years.44,45 PedsQL Epilepsy 
module was developed using focus groups.44,45 There is evi-
dence of structural validity and internal consistency for both 
child and parent report. Test-retest reliability was moderate 
(ICC = 0.59-0.83). Construct validity was demonstrated be-
tween similar scales and by discriminating known groups. 
Standard errors of measurement were reported across do-
mains ranging from 7.59 (Cognitive) to 12.61 (Sleep) for 
parent-report scales, and 8.44 (Impact) to 14.68 (Sleep) for 
child-report scales.
4 |  DISCUSSION
Our review identified 11 epilepsy-specific PROMs of chil-
dren's HRQoL. In particular, the QoLCE-55 questionnaire 
has good evidence of structural validity, construct validity, 
and internal consistency and this was replicated in other stud-
ies. CHEQoL is also a leading candidate, with good evidence 
of content validity, structural validity, and construct validity. 
Choosing between these two might be decided by QoLCE 
being only by parent-reported questionnaire, whereas 
CHEQoL can capture both child- and/or parent-reported 
HRQoL. Only 4 of the 11 PROMs had evidence to support 
content validity: CHEQoL, DISABKIDS epilepsy module, 
GEOS-YP, and PedsQL epilepsy module. Content validity 
is considered to be the most important measurement property 
because it is essential that items measure what the PROM 
purports they measure and that they are comprehensible to 
the target population.15
Based on our results, no PROM met the standard cri-
teria for all measurement properties, with evaluations on 
responsiveness and precision most lacking. Despite ev-
idence lacking for some measurement properties, the 
HARCES, CHEQoL, QoLCE-76, QoLCE-55, QoLCE-16, 
DISABKIDS Epilepsy Module, and GEOS-YP have good 
evidence in favor of at least two measurement properties 
in papers rated good or excellent for their methodological 
quality. There is more evidence for the QoLCE question-
naires as considerably more research has been published In
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evaluating them in comparison to other PROMs. It is im-
portant to remember this imbalance of research completed 
on the PROMs so that we do not dismiss a PROM that may 
be robust and useful but has not yet been fully validated 
and researched due to lack of resources.
Other reviews have also highlighted and evaluated the 
current condition-specific and generic PROMs that are 
available for use in childhood epilepsy.8‒14 One review 
identified that there were 13 epilepsy-specific PROMs for 
children and assessed the content of the PROMs with ref-
erence to the World Health Organization (WHO) defini-
tions.9 We identified nine of the same PROMs from this 
review. The previous PROMs that we did not include from 
the review were the Epilepsy Foundations of America 
Concerns Index (EFA), the Glasgow Epilepsy Outcome 
Scale (GEOS-C), the Impact of Childhood Neurologic 
Disability Scale (ICNDS), and the Epilepsy and Children 
Questionnaire (ECQ).46‒49 We did not include the EFA and 
GEOS-C because they are PROMs for adults. Some broader 
condition-specific neurological PROMs may be useful in 
epilepsy such as the ICNDs; however, these broader in-
struments were not included in the scope of our review.50 
The ECQ was validated in an Italian population. We also 
found two further childhood epilepsy-specific PROMs that 
were the GEOS-YP and PedsQL Epilepsy Module. Our 
review is an evaluation of the measurement properties of 
T A B L E  4  Summary appraisal of PROMs
Instrument version
Content 
validity
Structural 
validity
Construct 
validity
Internal 
consistency
Test-retest 
reliability
Proxy 
reliability Precision Responsiveness
Adult's Attitude to Children with Illness 
Scale
0 0 ? 0 0 0 0 0
Modified Impact of Epilepsy Schedule 0 0 ? 0 0 0 0 0
Impact of Childhood Illness Scale (ICI) ? + + ++ 0 0 0 0
Hague Restrictions in Childhood 
Epilepsy Scale (HARCES)
? 0 + ++ ++ 0 0 0
Quality of Life in Epilepsy inventory 
for Adolescents (QoLIE-AD-48)
? + + +/− ++ 0 0 0
Quality of Life in Paediatric Epilepsy 
(QoLPES)
+ 0 0 0 0 0 0 0
Quality of Life in Childhood Epilepsy 
(QoLCE-76)
? 0 +++ +++ 0 0 0 0
QoLCE-55 0 +++ +++ +++ 0 0 0 0
QOCLE-16 0 ++ + ++ 0 0 0 0
G-QoLCE 0 0 + 0 ? 0 0 +
Impact of Paediatric Epilepsy Scale 
(IPES)
0 + + ++ ? 0 0 ?
Health-Related Quality of Life 
Measure for Children with Epilepsy 
(CHEQoL-25)
++ ++ ++ +/− +/− − 0 0
DISABKIDS (Epilepsy Module) ++ ? 0 ++ 0 0 0 0
Epilepsy and Learning Disabilities 
Quality of Life (ELDQoL)
? 0 + ++ + 0 0 0
Glasgow Epilepsy Outcome Scale 
(GEOS-YP)
++ 0 ++ +/− + 0 0 0
PedsQL Epilepsy Module + + ++ +/− +/− 0 + 0
Note: Indices for summarising the measurement properties
0, Not reported: no studies found that evaluate this measurement property
?, Not clearly determined: studies were rated poor methodological quality; results not considered robust
−, Evidence not in favour: studies were rated good or excellent methodological quality; results did not meet standard criteria for this property
+/−, Conflicting evidence: studies were rated fair, good, or excellent methodological quality; results did not consistently meet standard criteria for this property eg not 
for all domain scales
+, Some evidence in favour: studies were rated fair or good methodological quality; standard criteria were met for the property
++, Some good evidence in favour: studies were rated good or excellent methodological quality standard criteria were met or exceeded
+++, Good evidence in favour: studies were rated good or excellent methodological quality; standard criteria were exceeded, results have been replicated
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epilepsy-specific PROMs for children and the only one to 
our knowledge that references the COSMIN methodology. 
Our review, in combination with information on the spe-
cific content of PROMs9, are key complementary resources 
that can aid clinicians and researchers in the selection of 
PROMs for a specific purpose.
We followed our peer-reviewed and published protocol, 
which describes a proportionate and pragmatic approach to 
review PROMs for children with epilepsy. We did not reg-
ister the review on PROSPERO; however, our protocol is 
publicly available.17 As outlined in our protocol, only one 
reviewer extracted evidence of measurement properties from 
the included studies (HC). Nevertheless, each paper was dis-
cussed extensively and appraised by two reviewers (HC and 
CM), and both were involved in assigning a summary rat-
ing while reviewing the papers. We also followed methodol-
ogy for assessing risk of methodological bias advocated by 
COSMIN.15,17 However, carrying out the appraisal using the 
most recent COSMIN checklists proved challenging at times. 
It was evident that many studies of PROMs, particularly those 
studies published more than 15 years previously, were not re-
ported in sufficient detail. For example, ICI and HARCES 
studies provided such limited information on the develop-
ment of the PROMs leading to harsh ratings of methodologi-
cal risk of bias. It is vital that PROM developers take account 
of potential methodological risks of bias and report adequate 
details of how measurement properties are evaluated.
It is important that an evaluation of a child's HRQoL 
provides the opportunity for the child to rate their own 
HRQoL alongside their parent/carer. For children, HRQoL 
is primarily about their social life and activities and per-
haps less about other factors that parents may deem import-
ant. Verhey et al39 found that agreement between parent 
proxy and child self-reports show lower parent agreement 
on abstract domains of HRQoL, similar to the findings of 
other studies.39 There were three PROMs that had parent 
and child parallel versions, but only the CHEQoL assessed 
parent proxy reliability. The CHEQoL parent-proxy mea-
sure should be used to complement to the child self-report 
measure and provides an independent parent perspective 
of a child's HRQoL.51‒53 However, there will be situations 
where children are not able to self-report or may not want 
to complete a questionnaire, and in those instances par-
ent-report can be considered separately. The COSMIN RoB 
checklist does not include a box to rate the bias of proxy 
reliability in studies. We made a strategic decision to use 
the checklist for the general reliability box, as we thought 
parent-proxy reliability was an important property to as-
sess and report on in our context.
Depending on your viewpoint, a potential strength or 
limitation of our systematic review was our strict inclusion 
criteria. We included only studies that were published, peer-re-
viewed evaluations of measurement properties of PROMs. 
Some experimental studies may report incidental data relat-
ing to measurement properties, even if not the purpose of that 
study. We limited the review to include only studies where 
English-language versions of PROMs were administered. 
This led to the exclusion of the ECQ developed in Italy, which 
showed promise for being a valid and reliable PROM in an 
Italian population of children.46 However, we cannot assume 
that measurement properties of PROMs are generalizable 
across different languages or cultures, which is a valid reason 
to exclude non–English-language versions of PROMs from 
this review. Our study focused on English-language versions 
of PROMs due to the objectives of the CASTLE research 
program, of which this work is a part of, and to inform trial 
design. However, we also recognize that research operates 
on an international level, and there will need to be reviews 
of evidence of validity and reliability when evaluated in lan-
guages other than English. We also included the ELDQoL, 
although it has a slightly different focus as it is for children 
with both epilepsy and learning disability. We included this 
PROM in the scope of our review because the questions are 
focused on aspects of epilepsy but asked in a way that is more 
appropriate to parents of children with a learning disabil-
ity. However, we did not include the Paediatric Refractory 
Epilepsy Questionnaire that was found in our search, as this 
would not be appropriate for all children with epilepsy.50
For clinicians and researchers to make an informed deci-
sion about which PROM to choose for a specific objective, 
there are other important properties to consider such as 
what constructs of HRQoL they measure, their importance 
to children with epilepsy and families, and how the ques-
tions and response options are understood by respondents. 
It is crucial to consider other important factors such as the 
content of a PROM and its face validity and acceptability 
to respondents. In a related paper,54 we examine the content 
of each PROM from this review and map the individual 
questions to our recently developed core outcome set for 
childhood epilepsy research.55 In addition, we report on our 
consultations with families of children with epilepsy about 
the acceptability and practicalities of using the QoLCE and 
CHEQoL.
In conclusion, from the evidence we have synthesized 
there are a small number of epilepsy-specific PROMs of chil-
dren's HRQoL with enough evidence of robust measurement 
properties to recommend them. In particular, the QoLCE-
55 and CHEQoL are leading candidates, of which only 
CHEQoL offers child self-reported HRQoL. It is also evident 
that parent proxy report is not always a reliable way of as-
sessing subjective HRQoL in children, and parent and child 
reports collected separately is the best way of ensuring that 
the child's HRQoL is assessed. There remains a pressing need 
for research to evaluate the responsiveness of these measures 
so we can interpret what constitutes meaningful change in 
scores over and above measurement error.
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